Caris Life Sciences is a molecular-science and precision-medicine company offering comprehensive tumor genomic profiling and AI-driven diagnostics to guide cancer treatment.
| Filer | 13FScore | This quarter | Shares | Value | % of their book |
|---|---|---|---|---|---|
| Louis Bacon / Moore | 53 | New buy | 63,895 | $1,138,609 | 0.0% |
| Stanley Druckenmiller / Duquesne | 95 | Holds (flat) | 1,894,450 | $33,759 | 0.6% |
| Paul Tudor Jones / Tudor | 63 | Holds (flat) | 100,327 | $1,787,827 | 0.0% |
| Filed | Insider | Role | Shares | Value | |
|---|---|---|---|---|---|
| 2026-07-13 | HALBERT JON | director | 68,000 | $990,080 | Form 4 |
| 2026-05-12 | Vacirca Jeff L | director | 31,050 | $501,426 | Form 4 |
Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-09-24.